14

Aug 2020

Aurobindo Pharma’s JV, Eugia Pharma receives FDA approval for Tamoxifen Citrate Tablets USP, 10 mg and 20 mg

East Windsor, N.J. – Aurobindo Pharma’s JV, Eugia Pharma has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Tamoxifen Citrate Tablets USP, 10 mg and 20 mg. Aurobindo’s  JV, Eugia Pharma Tamoxifen Citrate Tablets USP, 10 mg and 20 mg. are an AB-rated generic equivalent to the reference listed drug (RLD), Nolvadex® Tablets,... Read more

12

Aug 2020

Aurobindo Receives FDA Approval for Methocarbamol Tablets USP, 750 mg

East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Methocarbamol Tablets USP, 750 mg. Aurobindo’s Methocarbamol Tablets USP, 750 mg are an AB-rated generic equivalent to the reference listed drug (RLD), Robaxin-750® Tablets of Auxilium Pharmaceuticals, LLC. Methocarbamol Tablets are indicated for: Indicated as an adjunct... Read more

11

Aug 2020

Aurobindo received FDA Approval for Midodrine Hydrochloride Tablets USP, 2.5 mg, 5 mg, and 10 mg

East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Midodrine Hydrochloride Tablets USP, 2.5 mg, 5 mg, and 10 mg.  Aurobindo’s Midodrine Hydrochloride Tablets USP, 2.5 mg, 5 mg, and 10 mg, are an AB-rated generic equivalent to the reference listed drug (RLD), ProAmatine Tablets... Read more

31

Jul 2020

Aurobindo Receives FDA Approval for Anastrozole Tablets USP, 1 mg

East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Anastrozole Tablets USP, 1 mg. Aurobindo’s Anastrozole Tablets USP, 1 mg are an AB-rated generic equivalent to the reference listed drug (RLD), Arimidex Tablets, 1 mg, of ANI Pharmaceuticals, Inc. Anastrozole Tablets... Read more

31

Jul 2020

Aurobindo Receives FDA Approval for Imatinib Mesylate Tablets 100 mg and 400 mg

East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Imatinib Mesylate Tablets, 100 mg and 400 mg. Aurobindo’s Imatinib Mesylate Tablets, 100 mg and 400 mg are an AB-rated generic equivalent to the reference listed drug (RLD), Gleevec Tablets, 100 mg... Read more

31

Jul 2020

Aurobindo Pharma has received approval for Montelukast Sodium Oral Granules USP, 4mg

East Windsor, NJ–Aurobindo Pharma has received approval from the U.S. Food and Drug Administrationfor its Abbreviated New Drug Application Montelukast Sodium Oral Granules USP, 4mg. Aurobindo’s Montelukast Sodium Oral Granules USP, 4 mg are an AB-rated generic equivalent to the reference listed drug (RLD),SINGULAIR® of Merck & Co Inc. They will be available in 4... Read more

08

Apr 2020

Aurobindo Pharma has received approval for Tizanidine Hydrochloride capsules

East Windsor, NJ – Aurobindo Pharma has received approval from the U.S. Food and Drug Administration for its abbreviated new drug application for Tizanidine Hydrochloride capsules. Aurobindo’s Tizanidine Hydrochloride capsules are an AB-rated generic that is equivalent to the brand drug Zanaflex® and will be available in 2 mg, 4 mg, and 6 mg dose... Read more

07

Feb 2020

Aurobindo Receives FDA Approval for Trazodone Hydrochloride Tablets, 50 mg, 100 mg, 150 mg, and 300 mg.

East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Trazodone Hydrochloride Tablets, 50 mg, 100 mg, 150 mg, and 300 mg. Aurobindo’s Trazodone Hydrochloride Tablets, 50 mg, 100 mg, 150 mg, and 300 mg are an AB-rated generic equivalent to the... Read more

07

Feb 2020

Aurobindo Receives FDA Approval for Oxycodone Hydrochloride Oral Solution USP, 5 mg/5 mL (1 mg/mL) and 100 mg/5 mL (20 mg/mL).

East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Oxycodone Hydrochloride Oral Solution USP, 5 mg/5 mL (1 mg/mL) and 100 mg/5 mL (20 mg/mL). Aurobindo’s Oxycodone Hydrochloride Oral Solution USP, 5 mg/5 mL (1 mg/mL) and 100 mg/5 mL (20... Read more

07

Feb 2020

Aurobindo Receives FDA Approval for Methotrexate Tablets USP, 2.5 mg.

East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Methotrexate Tablets USP, 2.5 mg. Aurobindo’s Methotrexate Tablets USP, 2.5 mg are an AB-rated generic equivalent to the reference listed drug (RLD), Rheumatrex Tablets, 2.5 mg, of DAVA Pharmaceuticals, Inc. Methotrexate Tablets... Read more